Clinical trial
Efficacy and Safety of Human Insulin Versus Analog Insulin in Hospitalized Acute Stroke Patients With Hyperglycemia: a Randomized, Open-label, Single Center Trial
NCT04834362 is registered in ClinicalTrials.gov with National Institute of Neurosciences and Hospital, Dhaka as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Human Insulin Versus Analog Insulin in Hospitalized Acute Stroke Patients With Hyperglycemia: a Randomized, Open-label, Single Center Trial
- Lead sponsor
- National Institute of Neurosciences and Hospital, Dhaka
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 5, 2021
- Completion date
- June 25, 2021
- Enrollment
- 452 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hyperglycemia, stroke, acute